| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Squibb Institute for Medical Research, New Brunswick, New Jersey
Hydroxyurea prevented the leukocytosis that occurs in mice inoculated with L1210 leukemia. This activity probably accounted for the increase in survival time which was found in these animals when they were treated with hydroxyurea.
Hydroxyurea also reduced all blood cellular elements in the immature male rat in direct relationship to the dose employed. The highest daily dose employed in this study (125 mg/rat) also caused a reduction in body weight gain, food consumption, and endocrine organ weights.
Compounds related to hydroxyurea were also effective in reducing the number of RBC and WBC in the rat. Several of these decreased the WBC while not affecting the other end points examined.
Received 11/15/65. Accepted 6/ 1/66.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |